Qube Research & Technologies (QRT)
AVTX icon

Qube Research & Technologies (QRT)’s Avalo Therapeutics AVTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61M Buy
174,506
+110,043
+171% +$1.72M ﹤0.01% 2018
2025
Q4 		$1.17M Buy
+64,463
New +$1.09M ﹤0.01% 2487
2022
Q3 		– Sell
-15
Closed -$22K – 2500
2022
Q2 		$22K Buy
+15
New +$20.1K ﹤0.01% 2254

Other funds holding AVTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AVTX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Avalo Therapeutics (AVTX) stake by 171% in Q1 2026, buying an estimated $1.72M and bringing the position to 174,506 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2018.

Qube Research & Technologies (QRT) first reported a position in AVTX in Q2 2022 and has held it in 3 quarters since. 97 funds tracked by Wall St. Rank hold AVTX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 174,506 shares of Avalo Therapeutics worth $2.61M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 110,043 Avalo Therapeutics shares in Q1 2026, an estimated $1.72M.
  • Avalo Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2018 holding.
  • Qube Research & Technologies (QRT) first reported a position in Avalo Therapeutics in Q2 2022 and has held it in 3 quarters since.
  • 97 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.